New Real-World Evidence Generation Platform Released by Verantos

Verantos has announced the launch of its new real-world evidence (RWE) generation platform. The Verantos Evidence Platform, funded in part by the US National Science Foundation (NSF) and National Institute of Health (NIH), helps pharma and biotech companies accelerate therapeutic development, market access, and reimbursement decision-making. The platform is tailored to observational evidence, clinical trial recruitment, and more.

According to Verantos’s President Anand Shroff, “Regulatory bodies around the world are beginning to guide the industry towards high-validity real-world evidence. The Verantos Evidence Platform generates high-validity evidence with demonstrable accuracy, completeness, and traceability, all of which are growing areas of focus for life sciences organizations. In addition to providing high-validity evidence, the Verantos Evidence Platform enables innovative solutions for key areas such as observational research, trial recruitment, and value-based contracting”

To read more, click here.

(Source: PR Newswire, September 28^th, 2022)